Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
9.08
+0.02 (0.22%)
Nov 20, 2024, 4:00 PM EST - Market closed
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $1.00 billion as of November 21, 2024. Its market cap has increased by 40.55% in one year.
Market Cap
1.00B
Enterprise Value
785.87M
1-Year Change
40.55%
Ranking
Category
Stock Price
$9.08
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $1.00B, an increase of 707.10%. That is a compound annual growth rate of 61.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 1.00B | 97.62% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | 350.40M | 181.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Applied Therapeutics | 1.04B |
| Brookdale Senior Living | 1.04B |
| Avadel Pharmaceuticals | 1.03B |
| Zymeworks | 1.02B |
| Weave Communications | 999.15M |
| HealthStream | 980.58M |
| Phibro Animal Health | 961.96M |
| Collegium Pharmaceutical | 959.44M |